Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EHSG-KF versus split-thickness skin grafts for severe pediatric burns
NL-OMON55737Phase 2Not yet recruiting
- Sponsor
- CUTISS
- Start
- Oct 2017
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of denovoSkin in burn injury and deep partial-thickness burn (2 arms), sponsored by CUTISS. Primary endpoint: Ratio of covered surface area to biopsy site/donor site surface area. Planned start Oct 2017; status: not yet recruiting.
02
Drugs
denovoSkin
03
Conditions
burn injurydeep partial-thickness burn
Beyond the preview
Go deeper on NL-OMON55737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55737.